1. 1. Trapani D, Ginsburg O, Fadelu T, et al. (2022) Global challenges and policy solutions in breast cancer control. Cancer Treat Rev, 104:102339. [DOI:10.1016/j.ctrv.2022.102339] [PMID]

2. Fan L, Strasser-Weippl K, Li JJ, et al. (2014) Breast cancer in China. Lancet Oncol, 15(7):e279-89. [DOI:10.1016/S1470-2045(13)70567-9]

3. Eshaghi M (2020) The effect of pain management on pain reduction in women with breast cancer. SRPH Journal of Medical Sciences, 2(2) :1-5. [DOI:10.29252/sjmshm.2.2.1]

4. Zhang M, Peng P, Gu K, et al. (2018) Time-varying effects of prognostic factors associated with long-term survival in breast cancer. Endocr Relat Cancer, 25(5): 509-21. [DOI:10.1530/ERC-17-0502] [PMID] []

5. Cang B, zhou W, Cai L (2011) Analysis of survival related factors in 174 breast cancer. Practical Oncology Journal, 25(4): 3.

6. Tagliafico AS, Piana M, Schenone D, et al. (2020) Overview of radiomics in breast cancer diagnosis and prognostication. Breast, 49: 74-80. [DOI:10.1016/j.breast.2019.10.018] [PMID] []

7. Fowler AM and Strigel RM (2022) Clinical advances in PET-MRI for breast cancer. Lancet Oncol, 23(1): e32-e43. [DOI:10.1016/S1470-2045(21)00577-5]

8. Liang J, Zeng S, Li Z, et al. (2020) Intravoxel incoherent motion diffusion-weighted imaging for quantitative differentiation of breast tumors: A meta-analysis. Front Oncol, 10: 585486. [DOI:10.3389/fonc.2020.585486] [PMID] []

9. Uslu H, Onal T, Tosun M, et al. (2021) Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with molecular subtypes and histological grades. Magn Reson Imaging, 78: 35-41. [DOI:10.1016/j.mri.2021.02.005] [PMID]

10. Guo Y, Cai YQ, Cai ZL, et al. (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging, 16(2): 172-8. [DOI:10.1002/jmri.10140] [PMID]

11. Sinha S, Lucas-Quesada FA, Sinha U, et al. (2002) In-vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging, 15(6): 693-704. [DOI:10.1002/jmri.10116] [PMID]

12. Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology, 168(2): 497-505. [DOI:10.1148/radiology.168.2.3393671] [PMID]

13. Le Bihan D and Turner R. (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med, 27(1): 171-8. [DOI:10.1002/mrm.1910270116] [PMID]

14. De Robertis R, Tinazzi Martini P, Demozzi E, et al. (2015) Diffusion-weighted imaging of pancreatic cancer. World J Radiol, 7(10): 319-28. [DOI:10.4329/wjr.v7.i10.319] [PMID] []

15. Fang S, Yang Y, Chen B, et al. (2022) DWI and IVIM Imaging in a Murine Model of Rhabdomyosarcoma: Correlations with Quantitative Histopathologic Features. J Magn Reson Imaging, 55(1): 225-33. [DOI:10.1002/jmri.27828] [PMID]

16. Zhang Y, Luo D, Guo W, et al. (2023) Utility of mono-exponential, bi-exponential, and stretched exponential signal models of intravoxel incoherent motion (IVIM) to predict prognosis and survival risk in laryngeal and hypopharyngeal squamous cell carcinoma (LHSCC) patients after chemoradiotherapy. Jpn J Radiol, 41: 712-722. [DOI:10.1007/s11604-023-01399-x] [PMID] []

17. Chen W and Zheng R (2015) Incidence, mortality and survival analysis of breast cancer in China. Chinese Journal of Clinical Oncology, 24: 668-674.

18. Bloom HJ and Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11(3): 359-77. [DOI:10.1038/bjc.1957.43] [PMID] []

19. Parham DM (1995) Mitotic activity and histological grading of breast cancer. Pathol Annu, 30( Pt 1):189-207.

20. Carter D. Interpretation of Breast Biopsies. 4th Edition, 2002, Lippincott Williams & Wilkins, USA.

21. Le Doussal V, Tubiana-Hulin M, Friedman S, et al. (1989) Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer, 64(9): 1914-21. https://doi.org/10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G [DOI:10.1002/1097-0142(19891101)64:93.0.CO;2-G] [PMID]

22. Elston CW (1995) Pathology of the breast. The Breast, 4(1): 74-5. [DOI:10.1016/0960-9776(95)90059-4]

23. Aberle DR, Chiles C, Gatsonis C, et al. (2005) Imaging and cancer: research strategy of the American College of Radiology Imaging Network. Radiology, 235(3): 741-51. [DOI:10.1148/radiol.2353041760] [PMID]

24. Leung JW (2005) Screening mammography reduces morbidity of breast cancer treatment. AJR Am J Roentgenol, 184(5): 1508-9. [DOI:10.2214/ajr.184.5.01841508] [PMID]

25. Hopton DS, Thorogood J, Clayden AD, MacKinnon D (1989) Histological grading of breast cancer; significance of grade on recurrence and mortality. Eur J Surg Oncol, 15(1): 25-31.

26. Freedman LS, Edwards DN, McConnell EM, Downham DY (1979) Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer, 40(1): 44-55. [DOI:10.1038/bjc.1979.139] [PMID] []

27. Peters NH, Borel Rinkes IH, Zuithoff NP, et al. (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology, 246(1): 116-24. [DOI:10.1148/radiol.2461061298] [PMID]

28. Jones EF, Sinha SP, Newitt DC, et al. (2013) MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy. PLoS One, 8(5): e61969. [DOI:10.1371/journal.pone.0061969] [PMID] []

29. Costantini M, Belli P, Rinaldi P, et al. (2010) Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol, 65(12): 1005-12. [DOI:10.1016/j.crad.2010.07.008] [PMID]

30. Qin Y, Wu F, Hu Q, et al. (2023) Histogram analysis of multi-model high-resolution diffusion-weighted MRI in breast cancer: correlations with molecular prognostic factors and subtypes. Front Oncol, 13: 1139189. [DOI:10.3389/fonc.2023.1139189] [PMID] []